The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Feasibility of implantable microdosing devices to perform in vivo pharmacotyping in pancreatic cancer.
 
Lyudmyla Demyan
No Relationships to Disclose
 
Oliver Standring
No Relationships to Disclose
 
Taemoon Chung
No Relationships to Disclose
 
Emma Gazzara
No Relationships to Disclose
 
Scott Lyons
No Relationships to Disclose
 
Matthew John Weiss
No Relationships to Disclose
 
Youngkyu Park
No Relationships to Disclose
 
Oliver Jonas
No Relationships to Disclose
 
David A. Tuveson
Stock and Other Ownership Interests - Cygnal Therapeutics; Leap Therapeutics; Mestag Therapeutics; Surface Oncology
Consulting or Advisory Role - Cygnal Therapeutics; Leap Therapeutics; Mestag Therapeutics; Surface Oncology
Research Funding - FibroGen; Mestag Therapeutics; Ono Pharmaceutical
Patents, Royalties, Other Intellectual Property - anti-CA199 for pancreatitis (pending); We have filed a provisional use patent for 5B1 to use to treat pancreatitis. with MabVax, which was acquired by BionTech.
 
Daniel King
Stock and Other Ownership Interests - Illumina
Honoraria - Ipsen; Omni Health; Omni Health; Skysis